市場調查報告書
商品編碼
1470973
勝胜肽合成市場:按產品、技術和最終用戶分類 - 2024-2030 年全球預測Peptide Synthesis Market by Product (Equipment, Reagents, Services), Technology (Hybrid & Recombinant Technology, Solid-Phase Peptide Synthesis, Solution-Phase Synthesis), End User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年勝胜肽合成市場規模為6.3671億美元,2024年將達6.8344億美元,2030年將達10.8042億美元,複合年成長率為7.84%。
胜肽合成是一個複雜而複雜的化學過程,涉及胜肽的形成,肽是通過胜肽鍵連接的氨基酸短鏈。這些勝胜肽在各種生物系統中發揮多種重要作用,包括訊號傳導、細胞過程的調節和結構成分的維護。該技術以逐步的方式將氨基酸添加到生長的多肽鏈中,同時保護特定的官能基,確保整個過程的高保真度。由於其應用不斷擴大,對胜肽療法的需求不斷增加,各個經濟體的藥物研究活動和資金籌措都在增加。此外,化妝品行業對生物活性勝胜肽的需求不斷成長,從而促進了胜肽合成的廣泛採用。勝胜肽設計缺乏標準化規則和規定以及胜肽生產的困難阻礙了其利用。然而,先進的勝胜肽合成儀的引入、胜肽設計技術的食品以及胜肽在營養補充和食品保存中的潛在用途預計將在未來促進其合成。
主要市場統計 | |
---|---|
基準年[2023] | 63671萬美元 |
預測年份 [2024] | 6.8344億美元 |
預測年份 [2030] | 1,080,420,000 美元 |
複合年成長率(%) | 7.84% |
擴大產品合成過程中形成胜肽鍵的試劑的使用
勝胜肽合成中使用的設備包括自動合成器,可控制溫度、混合、過濾和其他參數以簡化流程。固相勝胜肽合成儀由於操作簡單且循環時間短而廣泛應用於最終用戶領域。其他重要設備包括用於精製和分析合成勝胜肽的高效液相層析(HPLC)系統、用於分子量測量的質譜儀以及用於乾燥和長期儲存勝胜肽的冷凍乾燥機。試劑構成合成過程中形成胜肽鍵所需的建構單元。常見試劑包括胺基酸(受保護或未受保護)、偶聯劑、胺基酸和其他產品。服務包括專門針對特定研究需求自訂胜肽合成的公司提供的專業知識。這些組織提供勝胜肽設計諮詢、使用各種策略(例如固相、溶液相和混合方法)的合成最佳化、精製、表徵和修飾等合成後處理、HPLC 和質譜分析。分析技術的品質保證。外包勝胜肽合成服務使研究人員能夠獲得資源和經驗來開發高產率和純度的複雜勝胜肽。
技術混合和重組技術在提供高勝胜肽產量和純度方面的潛力不斷成長
混合和重組技術結合了有機合成和生物技術製程的優點,提供高勝胜肽產量和純度。使用化學合成方法難以生產的複雜和長鏈胜肽可以靈活生產。透過修改基因序列,研究人員可以合成具有所需特性的特定勝胜肽。固相勝胜肽合成(SPPS)是最受歡迎的胜肽合成技術,能夠以工業規模生產短鏈至中鏈勝胜肽。這是一種有效且簡單的方法,使其成為合成具有明確功能特性的胜肽的首選方法。溶液相合成是一種傳統的胜肽合成方法,其中氨基酸溶解在溶劑中。長胜肽耗時且效率低,因此小胜肽需要大量生產。這個過程對於環胜肽的合成非常有用,並且產物需要後續的環化步驟。
最終用戶:擴大製藥和生物製藥公司在藥物發現中胜肽合成的使用
學術和研究機構使用胜肽合成來合成客自訂胜肽,這是闡明生物機制和研究分子相互作用的重要工具。這些合成勝胜肽廣泛用於新型療法的開發、藥物篩檢分析和包括生物標記在內的診斷應用。受託製造廠商(CDMO) 以及合約研究和開發組織 (CRO) 為製藥和生物技術客戶提供與勝胜肽設計、合成、精製和表徵相關的專業服務。利用固相和溶液相方法等先進的合成技術,我們能夠根據客戶的具體要求提供高品質的自訂胜肽。對於製藥和生物技術公司來說,胜肽合成對於藥物發現管道至關重要,以推動癌症、免疫治療、代謝疾病、感染疾病、發炎、疼痛管理和循環系統醫學等治療領域的進步。透過利用現有的實驗方法以及基於結構的藥物設計等先進的計算技術,這些公司可以最大限度地減少不必要的副作用和毒性,並開發出更有效和更具選擇性的生物藥物。
區域洞察
胜肽合成是整個美洲生化和藥物研究領域的重要技術。在北美,美國由於其成熟的生物製藥產業、廣泛的研究基礎設施以及對生命科學的大量投資,在胜肽合成的使用方面佔據主導地位。在南美洲,由於生物技術部門的擴大和政府對研究舉措的支持,巴西和墨西哥等國家擴大採用胜肽合成技術。亞太地區胜肽合成市場的強勁成長是由政府和私人公司不斷增加的研發投資、對新型治療解決方案的需求激增、該地區製藥和生物技術行業的足跡不斷擴大以及 CRO 的蓬勃發展所推動的。由於合成器的技術進步、研發活動資金的增加以及製藥、生物技術和其他行業對合成勝胜肽的需求不斷成長,歐洲、中東和非洲地區的胜肽合成市場正在經歷顯著成長。隨著新參與企業市場以及現有公司之間的合作不斷發生,胜肽合成的創新技術正在不斷開發。
FPNV定位矩陣
FPNV定位矩陣對於評估勝胜肽合成市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對胜肽合成市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4.競爭評估與資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.胜肽合成市場的市場規模與預測是多少?
2.在勝胜肽合成市場的預測期內,有哪些產品、細分市場、應用和領域需要考慮投資?
3.胜肽合成市場的技術趨勢和法規結構是什麼?
4.胜肽合成市場主要廠商的市場佔有率是多少?
5.進入勝胜肽合成市場合適的形式和策略手段是什麼?
[186 Pages Report] The Peptide Synthesis Market size was estimated at USD 636.71 million in 2023 and expected to reach USD 683.44 million in 2024, at a CAGR 7.84% to reach USD 1,080.42 million by 2030.
Peptide synthesis is a complex and advanced chemical process that entails the formation of peptides, which are short chains of amino acids linked by peptide bonds. These peptides play several critical roles in various biological systems, including signaling, regulation of cellular processes, and maintaining structural components. The technique involves adding amino acids to a growing polypeptide chain stepwise while protecting specific functional groups and ensuring high fidelity throughout the process. There is a higher demand for peptide therapeutics due to their increased applications, and pharmaceutical research activities and funding are on the rise across various economies. Moreover, the cosmetics industry is experiencing a growing need for bioactive peptides, contributing to increased peptide synthesis adoption. The lack of standardized rules and regulations for peptide design and difficulties in peptide production hinders its usage. However, the introduction of advanced peptide synthesizers and technologies developed for peptide design and the potential utilization of peptides in nutraceuticals and food preservation is expected to boost their synthesis in the future.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 636.71 million |
Estimated Year [2024] | USD 683.44 million |
Forecast Year [2030] | USD 1,080.42 million |
CAGR (%) | 7.84% |
Product: Growing usage of reagents for forming peptide bonds during synthesis
Equipment used in peptide synthesis includes automated synthesizers that streamline the process by controlling temperature, mixing, filtration, and other parameters. Solid-phase peptide synthesizers are widely used in end-user sectors due to their ease of operation and rapid cycle times. Other essential equipment includes high-performance liquid chromatography (HPLC) systems for the purification and analysis of synthesized peptides, mass spectrometers for determining molecular weight, and lyophilizers for drying and long-term storage of peptides. Reagents constitute the building blocks required for forming peptide bonds during synthesis. Common reagents include amino acids (protected or unprotected), coupling agents, amino acids, and other products. Services encompass expertise provided by companies specializing in custom peptide synthesis to cater to specific research needs. These organizations offer end-to-end solutions covering peptide design consultation, synthesis optimization using various strategies such as solid-phase, solution-phase, or hybrid methods, post-synthesis processing including purification, characterization, and modification, and quality assurance through analytical techniques such as HPLC, mass spectrometry, and amino acid analysis. Outsourcing peptide synthesis services enables researchers to access resources and experience in developing complex peptides with high yields and purity.
Technology: Rising potential of hybris & recombinant technology as it offers high peptide yield and purity
Hybrid & recombinant technology brings together the benefits of organic synthesis and biotechnological processes, offering high peptide yield and purity. It provides the flexibility to manufacture complex and long-chain peptides, which can be quite challenging for chemical synthesis methods. By modifying gene sequences, researchers can synthesize specific peptides with desired properties. Solid-phase peptide synthesis (SPPS) is the most prevalent technology in peptide synthesis, offering industrial-scale production of short to middle-length peptides. Being an efficient and straightforward approach, it is preferred for synthesizing peptides with clear functional properties. Solution-phase synthesis is the traditional method of peptide synthesis involving the dissolving of amino acids in a solvent. Large-scale manufacturing of smaller peptides as it is time-consuming and less efficient for longer peptides. The process is incredibly useful for the synthesis of cyclic peptides, where the product requires a subsequent cyclization step.
End-User: Expanding usage of peptide synthesis by pharmaceutical & biopharmaceutical companies for drug discovery
In academic and research institutes, peptide synthesis is employed to generate custom peptides that serve as essential tools for understanding biological mechanisms and investigating molecular interactions. These synthesized peptides are widely used to develop novel therapeutic agents, drug screening assays, and diagnostic applications involving biomarkers. Contract development & manufacturing organizations (CDMOs) and contract research organizations (CROs) provide specialized services related to the design, synthesis, purification, and characterization of peptides for clients in the pharmaceutical and biotechnology sectors. By leveraging advanced synthetic methodologies such as solid-phase peptide synthesis and solution-phase peptide synthesis techniques, these organizations can deliver high-quality custom peptides suited to their client's specific requirements. For pharmaceutical and biotechnology companies, peptide synthesis is integral to drug discovery pipelines as it drives advancements in therapeutic areas, including oncology, immunotherapy, metabolic disorders, infectious diseases, inflammation, pain management, and cardiovascular medicine, among others. Utilizing sophisticated computational methods such as structure-based drug design alongside well-established experimental practices enables these companies to develop more potent and selective bioactive molecules by minimizing unwanted side effects or toxicities.
Regional Insights
Peptide synthesis is a crucial technique in the field of biochemistry and pharmaceutical research across the Americas. In North America, the United States holds a dominant position in peptide synthesis usage due to its well-established biopharmaceutical industry, extensive research infrastructure, and considerable investment in life sciences. In South America, countries such as Brazil and Mexico are witnessing increased adoption of peptide synthesis technologies due to expanding biotechnology sectors and governmental support towards research initiatives. The Asia-Pacific peptide synthesis market's robust growth can be attributed to increased R&D investments by governments and private entities, surging demand for novel therapeutic solutions, expanding pharmaceutical & biotechnology industries' footprint within the region, and a thriving CRO landscape. The peptide synthesis market in the EMEA region is experiencing significant growth, driven by technological advancements in synthesizers, increased funding for research and development activities, and a growing demand for synthetic peptides in pharmaceuticals, biotechnology, and other industries. The market has witnessed an influx of new players and collaborations among existing participants to develop innovative technologies for peptide synthesis.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Peptide Synthesis Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Peptide Synthesis Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Peptide Synthesis Market, highlighting leading vendors and their innovative profiles. These include 2B Scientific Limited, AAPPTec, ABclonal, Inc., Advanced ChemTech, Almac Group Limited, AmbioPharm Inc., AnaSpec Inc., Bachem AG, Biocon Limited, Biosynth Ltd., Biotage, CEM Corporation, CPC Scientific Inc., Creative Diagnostics, Creative Peptides, CSBio, Enamine Ltd., GenScript Biotech Corporation, Gyros Protein Technologies AB, Hybio Pharmaceutical Co., Ltd., JPT Peptide Technologies GmbH by TheraCode GmbH, Kaneka Corporation, LifeTein LLC, Merck KGaA, New England BioGroup, LLC, Novo Nordisk A/S, PolyPeptide Group AG, Thermo Fisher Scientific Inc., and USV Private Limited.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Peptide Synthesis Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Peptide Synthesis Market?
3. What are the technology trends and regulatory frameworks in the Peptide Synthesis Market?
4. What is the market share of the leading vendors in the Peptide Synthesis Market?
5. Which modes and strategic moves are suitable for entering the Peptide Synthesis Market?
TA